Abstract

BackgroundAdvancing female age remains a difficult problem in infertility treatment. Ovarian angiogenesis plays an important role in follicular development and the activation of ovarian angiogenesis has been emerged as a new strategy for the improvement of age-related decline of oocyte quality. BMP-6 affect gonadotropin signals in granulosa cells and it promotes normal fertility by enabling appropriate response to LH and normal oocyte quality. BMP-6 has a potential role in regulation of angiogenesis and regulates the expression of inhibitor of DNA-binding proteins (Ids). Ids involved in the control and timing of follicle selection and granulosa cells differentiation. Especially, Id-1 is well-characterized target of BMP-6 signaling. Therefore, this study investigated whether co-administration of BMP-6 during superovulation process improves ovarian response, oocyte quality and expression of Id-1 and vascular endothelial growth factor (VEGF) in the ovary of aged female using a mouse model.MethodsAged C57BL/6 female mice (26–31 weeks old) were superovulated by injection with 0.1 mL of 5 IU equine chorionic gonadotropin (eCG) containing recombinant mouse BMP-6 at various doses (0, 0.01, 0.1, 1, and 10 ng), followed by injection with 5 IU human chorionic gonadotropin (hCG) 48 h later. Then, the mice were immediately paired with an individual male. The aged control group was superovulated without BMP-6. Young mice of 6–9 weeks old were superovulated without BMP-6 as a positive control for superovulation and in vitro culture of embryos. Eighteen hours after hCG injection, zygotes were retrieved and cultured for 4 days. Both ovaries of each mouse were provided in the examination of ovarian expression of Id-1 and VEGF by reverse transcriptase-polymerase chain reaction, western blot, and immunohistochemistry.ResultsAdministration of 0.1 ng BMP-6 significantly increased the number and blastocyst formation rate of oocytes ovulated and ovarian expression of Id-1 and VEGF compared to aged control mice. These increased levels were comparable to those of young control mice.ConclusionsThis result suggests that BMP-6 during ovulation induction plays an important role in improvement of oocyte quality and ovarian response of aged female, possibly by regulating of ovarian Id-1 and VEGF expression.

Highlights

  • Advancing female age remains a difficult problem in infertility treatment

  • This study examined whether Bone morphogenetic proteins (BMPs)-6 administration during superovulation process affects ovarian response, oocyte quality and expression of inhibitor of DNA-binding proteins (Ids)-1 and vascular endothelial growth factor (VEGF) in the ovary of aged female using a mouse model

  • To investigate whether BMP-6 effects on ovarian response and developmental competency of oocytes in aged female mice, BMP-6 was co-administered to female mice of 26–31 weeks old at different doses (0, 0.01, 0.1, 1, and 10 ng) during superovulation

Read more

Summary

Introduction

Ovarian angiogenesis plays an important role in follicular development and the activation of ovarian angiogenesis has been emerged as a new strategy for the improvement of age-related decline of oocyte quality. Ovarian angiogenesis plays an important role in follicular growth and the selection of dominant follicle by allowing the delivery of adequate nutrition, hormonal supply and oxygen from stromal blood vessels to induce oocytes with high quality [3,4,5,6]. Tatone et al [7] suggested a possible mechanism that age-related nuclear and cytoplasmic damage may occur as a result of inadequate ovarian angiogenesis in primordial follicles as well as in ovarian stroma vessels These results suggest that the activation of ovarian angiogenesis could be a new strategy for the improvement of age-related decline of oocyte quality

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call